NCT05886491
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05886491
Title A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Takeda
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham (UAB) Hospital Birmingham Alabama 35205 United States Details
City of Hope Duarte California 91010 United States Details
Sarah Cannon/CBCI Denver Colorado 80218 United States Details
Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University St Louis Missouri 63110 United States Details
Thomas Jefferson University New York New York 10065 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Tri-Star BMT/Sarah Cannon Nashville Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
National Cancer Center Hospital East Kashiwa 277-8577 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field